TFG Advisers’s Rockwell Medical RMTI Stock Holding History

TFG Advisers’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13	Closed	-$3K	–	380
2019 Q4	$3K	Buy	+13	New	+$3.27K	﹤0.01%	446

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

TFG Advisers's RMTI Position: Q1 2020 in Review

TFG Advisers sold out of Rockwell Medical (RMTI) in Q1 2020, closing a stake of 13 shares — an estimated $3K sold.

TFG Advisers first reported a position in RMTI in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 79 funds tracked by Wall St. Rank hold RMTI as of Q1 2020.

TFG Advisers reported no remaining Rockwell Medical position as of Q1 2020 after selling out during the quarter.
TFG Advisers sold 13 Rockwell Medical shares in Q1 2020, an estimated $3K.
TFG Advisers first reported a position in Rockwell Medical in Q4 2019 and held it in 1 quarter.
TFG Advisers's Rockwell Medical position peaked at $3K in Q4 2019.
79 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2020.

Based on TFG Advisers's 13F filing for Q1 2020, filed 24 Apr 2020.